CSPC Pharmaceutical Group Limited

Update in progress

1093.HK (HKSE)

Company RatingNeutral
SectorHealthcare
IndustryDrug Manufacturers - General

CSPC Pharmaceutical Group Limited is an investment holding company that manufactures and sells pharmaceutical products in Mainland China, Asia, Europe, North America, and beyond. It operates via Finished Drugs, Bulk Products, and Functional Food and Others, offering a broad range of medicines, vitamins, APIs, functional foods, and healthcare services. It collaborates with AstraZeneca to develop novel oral candidates. The company was founded in 1992, formerly China Pharmaceutical Group, and is based in Shijiazhuang.

Company score

Sentiment: 0.41; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.01; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.12; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.05; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.05; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.23; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive